TEVA icon

Teva Pharmaceuticals

425 hedge funds and large institutions have $3.73B invested in Teva Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 130 increasing their positions, 137 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
425
Holders Change
-11
Holders Change %
-2.52%
% of All Funds
6.7%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.21%
New
50
Increased
130
Reduced
137
Closed
60
Calls
$162M
Puts
$145M
Net Calls
+$16.5M
Net Calls Change
+$50.3M
Name Holding Trade Value Shares
Change
Shares
Change %
GI
351
Gradient Investments
Minnesota
$8.67K
AF
352
Allworth Financial
California
$7.92K +$4.52K +600 +133%
BWA
353
BDO Wealth Advisors
Florida
$7.53K
ACM
354
Antonetti Capital Management
Florida
$6.42K
AA
355
AlphaMark Advisors
Kentucky
$6K
JEST
356
JTC Employer Solutions Trustee
Jersey
$6K
ZB
357
Zions Bancorporation
Utah
$5.4K
HI
358
Harbour Investments
Wisconsin
$5.29K +$452 +60 +9%
CT
359
Colonial Trust
South Carolina
$5.02K
CMP
360
Coston McIsaac & Partners
Maine
$5K
LC
361
Lindbrook Capital
California
$4.74K -$1.18K -157 -20%
MAWCM
362
Mine & Arao Wealth Creation & Management
California
$4.52K
LFG
363
Larson Financial Group
Missouri
$4.46K
PLU
364
Performa Ltd (US)
South Carolina
$4.41K
BC
365
Bartlett & Co
Ohio
$4K
HS
366
Horan Securities
United States
$3.84K
BCWM
367
Bartlett & Co Wealth Management
Ohio
$3.77K
SSB
368
Sandy Spring Bank
Maryland
$3.77K
QC
369
Quent Capital
New York
$3.77K
JWA
370
JFS Wealth Advisors
Pennsylvania
$3.74K -$1.82K -241 -33%
OP
371
ORG Partners
Indiana
$3.74K +$3.74K +500 New
RA
372
Rise Advisors
New York
$3.69K -$2.26K -300 -38%
GWS
373
Glassman Wealth Services
Virginia
$3.25K -$459 -61 -12%
Fifth Third Bancorp
374
Fifth Third Bancorp
Ohio
$3.22K -$437 -58 -12%
GRP
375
Global Retirement Partners
California
$3.13K